TY - JOUR T1 - Using biomarkers to adjust corticosteroid dose in patients with severe asthma JF - Breathe JO - Breathe DO - 10.1183/20734735.0324-2020 VL - 17 IS - 1 SP - 200324 AU - Thomas L. Jones Y1 - 2021/03/01 UR - http://breathe.ersjournals.com/content/17/1/200324.abstract N2 - In the management of airway disease, escalation of treatment often happens more readily than reduction. In line with this, clinical trials usually focus on the up-titration or addition of medications and few trials are available to also guide reduction in treatment.Use of biomarkers may help reduce inhaled corticosteroid burden in severe asthma if treatment advice is followed. T2 low asthma is less common than previously thought. https://bit.ly/3rG7SZ2 ER -